Vaiomer is happy to announce that we will be attending the 8th IHMC Virtual Congress 2021 on June 27, 28 & 29...
Highlights Articles
Vaiomer will attend the 8th IHMC Congress. Join us on our virtual stand to chat about microbiomes.
read more
Vaiomer taking part in Pharmabiotics 2021, 28-29 april
#Microbiome #BeyondTheGut #MicrobiomeScience #ClinicalResearch
Vaiomer taking part in Pharmabiotics 2021
Join the virtual conference, watch our presentation, take part in our roundtable and share in one-on-one meetings...
MICROB-INNOV de Vaiomer a été sélectionné parmi les 32 nouveaux projets lauréats du volet “(re)-localisation – secteurs stratégiques – santé” du plan FRANCE RELANCE.
Vaiomer lauréat du Plan France Relance (re)Localisation des Secteurs Stratégiques -Santé
MICROB-INNOV de Vaiomer a été sélectionné parmi les 32 nouveaux projets lauréats du volet "(re)-Localisation -...
In March 2020 on the cover of Nature Metabolism, Anhê and colleagues demonstrated why blood and tissue microbiomes are crucial to understanding the interactions between gut microbiota dysbiosis and metabolic diseases in humans. more
Tissue microbiomes: recent highlights in Type 2 diabetes
Exploring the tissue microbiomes, from adipose tissue and liver, to understand the link between obesity and type 2...
Schierwagen and colleagues (2019) described the circulating microbiome from different compartments accessible during the implantation of a transjugular intrahepatic portosystemic shunt (TIPS). more
Circulating microbiome: controlling contamination for reliable data
Circulating microbiome advances rely on strong contamination-aware metagenomics using negative controlsSchierwagen and...
A plethora of studies has associated the intestinal microbiota with numerous diseases including obesity and type 2 diabetes (T2D). more
Bacterial translocation and tissue microbiomes: Vaiomer founding work
The role of bacterial translocation in diabetes and the characterization of healthy tissue microbiotaA plethora of...





